Literature DB >> 10193359

Prognosis and sleep disordered breathing in heart failure.

I Wilcox1, S G McNamara, T Wessendorf, G N Willson, A J Piper, C E Sullivan.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 10193359      PMCID： PMC1765916          DOI： 10.1136/thx.53.2008.s33

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  19 in total

1.  The mechanism of Cheyne-Stokes respiration.

Authors:  R L LANGE; H H HECHT
Journal:  J Clin Invest       Date:  1962-01       Impact factor: 14.808

2.  Heart failure therapy in evolution.

Authors:  K Chatterjee
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690

Review 3.  The epidemiology of heart failure.

Authors:  M R Cowie; A Mosterd; D A Wood; J W Deckers; P A Poole-Wilson; G C Sutton; D E Grobbee
Journal:  Eur Heart J       Date:  1997-02       Impact factor: 29.983

4.  Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension?

Authors:  J Hedner; H Ejnell; J Sellgren; T Hedner; G Wallin
Journal:  J Hypertens Suppl       Date:  1988-12

5.  Cheyne-Stokes respiration and prognosis in congestive heart failure.

Authors:  S Andreas; G Hagenah; C Moller; G S Werner; H Kreuzer
Journal:  Am J Cardiol       Date:  1996-12-01       Impact factor: 2.778

6.  AHA president's letter.

Authors:  S C Smith
Journal:  Circulation       Date:  1995-07-01       Impact factor: 29.690

7.  Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure.

Authors:  P J Hanly; N S Zuberi-Khokhar
Journal:  Am J Respir Crit Care Med       Date:  1996-01       Impact factor: 21.405

8.  Respiration and abnormal sleep in patients with congestive heart failure.

Authors:  P J Hanly; T W Millar; D G Steljes; R Baert; M A Frais; M H Kryger
Journal:  Chest       Date:  1989-09       Impact factor: 9.410

9.  Blood pressure, catecholamines, and pancreatic polypeptide in obstructive sleep apnea with and without nasal Continuous Positive Airway Pressure (nCPAP) treatment.

Authors:  P Jennum; G Wildschiødtz; N J Christensen; T Schwartz
Journal:  Am J Hypertens       Date:  1989-11       Impact factor: 2.689

10.  Cheyne-Stokes breathing during sleep in patients with left ventricular heart failure.

Authors:  L J Findley; C W Zwillich; S Ancoli-Israel; D Kripke; G Tisi; K M Moser
Journal:  South Med J       Date:  1985-01       Impact factor: 0.954
View more
  4 in total

Review 1.  Central sleep apnoea syndrome in patients with chronic heart disease: a critical review of the current literature.

Authors:  T Köhnlein; T Welte; L B Tan; M W Elliott
Journal:  Thorax       Date:  2002-06       Impact factor: 9.139

Review 2.  Impact of heart failure on quality of sleep.

Authors:  A Rao; D Gray
Journal:  Postgrad Med J       Date:  2005-02       Impact factor: 2.401

3.  A novel approach to the treatment of central sleep apnea in patients with heart failure.

Authors:  R Augostini
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2012-03

4.  Cheyne-stokes respiration and prognosis in modern-treated congestive heart failure.

Authors:  Gerrit Hagenah; Antonia Zapf; Jan Bernd Schüttert
Journal:  Lung       Date:  2009-12-12       Impact factor: 2.584
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.